Dhampur Bio Organics Limited
Dhampur Bio Organics Limited Fundamental Analysis
Dhampur Bio Organics Limited (DBOL.NS) shows weak financial fundamentals with a PE ratio of 26.81, profit margin of 1.17%, and ROE of 2.40%. The company generates $20.3B in annual revenue with weak year-over-year growth of -23.60%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 14.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze DBOL.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakDBOL.NS struggles to generate sufficient returns from assets.
Valuation Score
ModerateDBOL.NS shows balanced valuation metrics.
Growth Score
WeakDBOL.NS faces weak or negative growth trends.
Financial Health Score
ExcellentDBOL.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateDBOL.NS maintains healthy but balanced margins.
Key Financial Metrics
Is DBOL.NS Expensive or Cheap?
P/E Ratio
DBOL.NS trades at 26.81 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, DBOL.NS's PEG of 0.27 indicates potential undervaluation.
Price to Book
The market values Dhampur Bio Organics Limited at 0.66 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.66 times EBITDA. This is generally considered low.
How Well Does DBOL.NS Make Money?
Net Profit Margin
For every $100 in sales, Dhampur Bio Organics Limited keeps $1.17 as profit after all expenses.
Operating Margin
Core operations generate 8.14 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.40 in profit for every $100 of shareholder equity.
ROA
Dhampur Bio Organics Limited generates $1.44 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Dhampur Bio Organics Limited generates strong operating cash flow of $6.89B, reflecting robust business health.
Free Cash Flow
Dhampur Bio Organics Limited generates strong free cash flow of $6.69B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $100.84 in free cash annually.
FCF Yield
DBOL.NS converts 1.05% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
26.81
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.27
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.66
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.31
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.58
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.13
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
0.14
vs 25 benchmark
How DBOL.NS Stacks Against Its Sector Peers
| Metric | DBOL.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 26.81 | 22.35 | Worse (Expensive) |
| ROE | 2.40% | 1280.00% | Weak |
| Net Margin | 1.17% | -5505.00% (disorted) | Weak |
| Debt/Equity | 0.58 | 0.83 | Strong (Low Leverage) |
| Current Ratio | 1.13 | 2.43 | Neutral |
| ROA | 1.44% | -199583.00% (disorted) | Weak |
DBOL.NS outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Dhampur Bio Organics Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
0.00%
Industry Style: Defensive, Dividend, Low Volatility
DecliningEPS CAGR
301169.99%
Industry Style: Defensive, Dividend, Low Volatility
High GrowthFCF CAGR
-656114.72%
Industry Style: Defensive, Dividend, Low Volatility
Declining